Conference results

Showing 1 posts of 1 posts found.

Eisai presents latest findings for lecanemab at Alzheimer’s Association International Conference (AAIC)

July 31, 2024
Research and Development Alzheimers, Conference results, Eisai, Neurology

Clarity AD open-label extension (OLE) data show: three years of continuous lecanemab treatment reduced clinical decline by -0.95 vs expected …

The Gateway to Local Adoption Series

Latest content